| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Financial Officer
3 companies
Gagnon Robert E. is a Chief Financial Officer at IRD with holdings across 3 companies. Recent SEC Form 4 filings include 5 buys and 0 sells.
Estimated insider holdings value: $1.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 26, 2017 | HBIO Harvard Bioscience Inc | Chief Financial Officer | Buy | 1,000 | $2.33 | $2,330.00 | +0.2% | |
| Nov 3, 2016 | HBIO Harvard Bioscience Inc | Chief Financial Officer | Buy | 25,000 | $2.34 | $58,450.00 | +5.1% | |
| Nov 12, 2015 | HBIO Harvard Bioscience Inc | Chief Financial Officer | Buy | 1,500 | $2.93 | $4,395.00 | +2.3% | |
| Nov 9, 2015 | HBIO Harvard Bioscience Inc | Chief Financial Officer | Buy | 3,000 | $3.08 | $9,240.00 | +4.7% |